Active Fine Chemicals Limited produces and sells bulk drugs/active pharmaceutical ingredients (APIs) and various laboratory reagents in Bangladesh. The company’s APIs include azithromycin dihydrate, erythromycin ethyl succinate, and erythromycin stearate for macrolide-antibiotics; esomeprazole magnesium trihydrates and pellets for anti-ulcerant; fluconazoles for anti-fungal; atorvastatin and rosuvastatin calcium for lipid-lowering; cetirizine and fexofenadine hydrochlorides, desloratadines, and ebastine for anti-histamine; and ciprofloxacin hydrochloride for anti-bacterial therapeutics. It also offers cefixime trihydrates and cefuroxime axetil for cephalosporin-antibiotics; metformin hydrochloride, sitagliptin phosphate monohydrate, vildagliptin, linagliptin, gliclizide, and glimepiride for anti-diabetic; pregabalin for anti-epileptic; paracetamol for analgesic and antipyrotic; losartan potassium and amlodipine besylate for anti-hypertensive; calcium orotate for use in calcium-supplement; sofosbuvir for anti-hepatitis-C; etoricoxib and ketorolac tromethamine for NSAID; and ticagrelor and amlodipine besylate for anti-platelet therapeutic areas, as well as solvents and powder reagents. Active Fine Chemicals Limited was incorporated in 2004 and is based in Dhaka, Bangladesh.
Metrics to compare | ACFC | Peers Peers - average of corresponding metrics from companies closely matching ACFC: TECHNODRUG, CENTRALPHL, 531240, ELVN, FFNT.F | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACFCPeersSector |
---|---|---|---|---|
P/E Ratio | 0.0x | −1.5x | −0.5x | |
PEG Ratio | 0.00 | 0.03 | 0.00 | |
Price/Book | 0.0x | 1.0x | 2.6x | |
Price / LTM Sales | 0.0x | 0.8x | 3.3x | |
Upside (Analyst Target) | 0.0% | 190.0% | 43.4% | |
Fair Value Upside | Unlock | −6.7% | 7.1% | Unlock |